,Group,Gilenya_pat,Gilenya_relapse,Gilenya_relapse_rate,Tecfidera_pat,Tecfidera_relapse,Tecfidera_relapse_rate,actual_treatment,expect_Gilenya_relapse_rate,expect_Tecfidera_relapse_rate,expect_treatment
training,lowest 35%,622,75,0.120578778135048,307,81,0.263843648208469,-0.143264870073421,0.112346770527507,0.258652156259043,-0.146305385731536
training,middle 30%,492,25,0.0508130081300813,305,20,0.0655737704918033,-0.014760762361722,0.0623837027421173,0.0759580681962865,-0.0135743654541692
training,highest 35%,615,103,0.167479674796748,314,25,0.0796178343949045,0.0878618404018435,0.16193915403112,0.0787896363876594,0.0831495176434609
test,lowest 50%,193,26,0.134715025906736,139,14,0.100719424460432,0.0339956014463041,0.0999217451971904,0.215405220072588,-0.115483474875398
test,highest 50%,227,26,0.114537444933921,104,16,0.153846153846154,-0.0393087089122331,0.144520269685668,0.079004766991619,0.0655155026940494
